Expert Discusses Disruptors, High-Cost Drugs in Marketplace

Commentary
Video

Christina Barrington, PharmD, vice president of pharmacy programs at Priority Health, discusses current disruptors in the marketplace and high-cost drugs.

Christina Barrington, PharmD, vice president of pharmacy programs at Priority Health, discusses current disruptors in the marketplace and high-cost drugs.

Q: What key challenges are facing managed care pharmacies, and how do you use the wealth of data to address those challanges?

There are so many disruptors right now in the marketplace. We have high-cost drugs. We have legislation that's impacting us on a daily basis. We have new programs that are in the market that we would like to be able to offer. Our members, many times, cannot participate in all of those. I think for us keeping pharmacy affordable so that our members have access to the drugs that they need at a cost that they can afford.

Pharmacist writing prescription pharmacy counter | Image Credit: Jacob Lund - stock.adobe.com

Jacob Lund - stock.adobe.com

Q: How can pharmacists help to address these challenges?

I have a team of pharmacists on a daily basis that are looking for opportunities for us to appropriately manage the medications that we cover to develop benefits that are affordable for our members. They also do predictive modeling, so that we can predict how a new medication or therapeutic area might impact our costs, so that we can help mitigate that trend so we can keep premiums low and copays low for our members.

Related Videos
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
pain management palliative care/Image Credits: © Aleksej - stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
palliative and hospice care/ Image Credits: © David Pereiras - stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.